Cargando…
Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207246/ http://dx.doi.org/10.1093/europace/euad122.017 |
_version_ | 1785046409760735232 |
---|---|
author | Gregusova, N Grossi, B Pagani, S Taormina, A Cariotti, C Poggio, L Galimberti, P Battaglia, V Del Monaco, G Latini, A C Valcher, S Stankowski, K Mincione, G Condorelli, G Frontera, A |
author_facet | Gregusova, N Grossi, B Pagani, S Taormina, A Cariotti, C Poggio, L Galimberti, P Battaglia, V Del Monaco, G Latini, A C Valcher, S Stankowski, K Mincione, G Condorelli, G Frontera, A |
author_sort | Gregusova, N |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target for ablation of AF patients. PURPOSE: The purpose of this study is to analyse whether structural atrial conduction abnormalities (i.e., pivot sites and slow conduction corridors) may occur outside low voltage areas. METHODS: The study is based on the retrospective analysis of 31 consecutive maps of patients undergoing AF ablation (16 paroxysmal and 15 persistent cases). The clinical procedures have been performed with the support of a mapping system. Sinus rhythm activation maps and bipolar maps used for this analysis have been created with a multipolar mapping catheter. Map points were only acquired when the electrode was in contact with the endocardial tissue to avoid misleading voltage amplitude information. Slow conduction corridors and pivot sites have been analysed. At these sites, EGMs characterization included voltage amplitude (mV), signal duration (ms) and fractionation. RESULTS: The average value of EGMs amplitude reported at pivot sites and slow conduction zones, respectively, amounted to 2,08 ± 0,63 mV and 2,1 ± 0,66 mV in paroxysmal cases. In persistent cases, there were slight decreased values to 1,95 ± 0,93 mV and 1,89 ± 0,89 mV. Characterization at pivot sites documented a mean duration value of 45,4 ± 4,64 ms and 49,93 ± 5,51 ms in paroxysmal and persistent patients, respectively, while in slow conduction zones 41,53 ± 7,94 ms and 49,04 ± 6,41 ms have been reported. As for fractionation, more than five deflections per signal have been identified in all abnormal conduction areas. CONCLUSION: Our study proves that functional electrophysiological phenomena can occur outside low voltage areas, even in persistent cases. According to this analysis, not all LVA represent the correct target for catheter ablation, encouraging the development of further methods for investigation of atrial substrate. |
format | Online Article Text |
id | pubmed-10207246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102072462023-05-25 Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation Gregusova, N Grossi, B Pagani, S Taormina, A Cariotti, C Poggio, L Galimberti, P Battaglia, V Del Monaco, G Latini, A C Valcher, S Stankowski, K Mincione, G Condorelli, G Frontera, A Europace 10.1.99 - Pathophysiology and Mechanisms, Other FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: In case of persistent atrial fibrillation (AF), atrial substrate assumes a dominant role in sustaining the arrhythmia. Recent studies prove that low voltage areas (LVA, Voltage Amplitude < 0,5 mV) represent an additional target for ablation of AF patients. PURPOSE: The purpose of this study is to analyse whether structural atrial conduction abnormalities (i.e., pivot sites and slow conduction corridors) may occur outside low voltage areas. METHODS: The study is based on the retrospective analysis of 31 consecutive maps of patients undergoing AF ablation (16 paroxysmal and 15 persistent cases). The clinical procedures have been performed with the support of a mapping system. Sinus rhythm activation maps and bipolar maps used for this analysis have been created with a multipolar mapping catheter. Map points were only acquired when the electrode was in contact with the endocardial tissue to avoid misleading voltage amplitude information. Slow conduction corridors and pivot sites have been analysed. At these sites, EGMs characterization included voltage amplitude (mV), signal duration (ms) and fractionation. RESULTS: The average value of EGMs amplitude reported at pivot sites and slow conduction zones, respectively, amounted to 2,08 ± 0,63 mV and 2,1 ± 0,66 mV in paroxysmal cases. In persistent cases, there were slight decreased values to 1,95 ± 0,93 mV and 1,89 ± 0,89 mV. Characterization at pivot sites documented a mean duration value of 45,4 ± 4,64 ms and 49,93 ± 5,51 ms in paroxysmal and persistent patients, respectively, while in slow conduction zones 41,53 ± 7,94 ms and 49,04 ± 6,41 ms have been reported. As for fractionation, more than five deflections per signal have been identified in all abnormal conduction areas. CONCLUSION: Our study proves that functional electrophysiological phenomena can occur outside low voltage areas, even in persistent cases. According to this analysis, not all LVA represent the correct target for catheter ablation, encouraging the development of further methods for investigation of atrial substrate. Oxford University Press 2023-05-24 /pmc/articles/PMC10207246/ http://dx.doi.org/10.1093/europace/euad122.017 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 10.1.99 - Pathophysiology and Mechanisms, Other Gregusova, N Grossi, B Pagani, S Taormina, A Cariotti, C Poggio, L Galimberti, P Battaglia, V Del Monaco, G Latini, A C Valcher, S Stankowski, K Mincione, G Condorelli, G Frontera, A Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title | Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title_full | Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title_fullStr | Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title_full_unstemmed | Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title_short | Voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
title_sort | voltage characterization of abnormal conduction zones in patients affected by atrial fibrillation |
topic | 10.1.99 - Pathophysiology and Mechanisms, Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207246/ http://dx.doi.org/10.1093/europace/euad122.017 |
work_keys_str_mv | AT gregusovan voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT grossib voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT paganis voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT taorminaa voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT cariottic voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT poggiol voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT galimbertip voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT battagliav voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT delmonacog voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT latiniac voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT valchers voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT stankowskik voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT mincioneg voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT condorellig voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation AT fronteraa voltagecharacterizationofabnormalconductionzonesinpatientsaffectedbyatrialfibrillation |